IOL Chemicals and Pharmaceuticals Q3 FY23 income down 6%
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
Net sales for 9M FY23 up 9% to Rs. 4,246 crore and net profit for 9M FY23 at Rs. 189 crore
A pharma industry veteran with over three decades of experience in domestic as well as international markets
The company is proud to be at the forefront of promoting cancer awareness and hopes to make a positive impact on the lives of its employees
On the day dedicated to the battle against the deadly disease – took to reaching the public of Pune to understand that cancer can be prevented and even reversed with the help of adequate testing
The players and management of Mumbai City FC presented patients with exclusive gifts, symbolizing support and appreciation for their fight against cancer
He is a Chartered Accountant with more than 19 years of extensive experience
Experts’ conclave to pave holistic approach to cancer management
Theramex were searching for a platform to digitise the manual processes across their R&D landscape
During the quarter, foreign exchange fluctuations had an impact of Rs. 4.56 crore Q3 FY23 Profit After Tax after considering exchange rate fluctuations stood at Rs. 8.2 crore
Subscribe To Our Newsletter & Stay Updated